Oratane Capsules

2450

Description

Oratane Capsules

Contraindications: Renal or hepatic impairment, hyperlipidaemia, hypervitaminosis A. Soya or peanut allergy. Pregnancy (teratogenic), women of childbearing potential unless all conditions of pregnancy prevention programme are met. Precautions: Prescription must be written by a named dermatologist. Exclude pregnancy before starting treatment; effective contraceptive measures must be taken by women of child-bearing potential for 1 mth before, during and for at least 4 wks after therapy. Monitor liver function before starting treatment, 1 mth later and then at 3 mth intervals; reduce dose or discontinue if transaminase levels exceed normal. Monitor fasting serum lipids before starting treatment, 1 mth later and then at end of treatment; discontinue if hypertriglyceridaemia is uncontrolled or symptoms of pancreatitis occur. History of depression; monitor all patients for signs of depression and suicidal ideation. Avoid dermabrasion for 5-6 months, or wax epilation for minimum 6 months, after treatment. History of intestinal disorders; discontinue if severe diarrhoea. Risk of serious skin reactions; advise patients to report symptoms and discontinue if occur. Avoid blood donation for 1 month after last dose. Renal impairment, diabetes, obesity, alcoholism, dyslipidaemia.

Reviews

There are no reviews yet.

Be the first to review “Oratane Capsules”

Your email address will not be published. Required fields are marked *